Gerdau S.A. (GGB) Reaches $4.66 52-Week High; Marsico Capital Management Has Trimmed By $2.21 Million Its Amgen (AMGN) Stake

January 13, 2018 - By Henry Gaston

The stock of Gerdau S.A. (NYSE:GGB) hit a new 52-week high and has $5.03 target or 8.00% above today’s $4.66 share price. The 5 months bullish chart indicates low risk for the $7.91 billion company. The 1-year high was reported on Jan, 13 by If the $5.03 price target is reached, the company will be worth $632.96M more. The stock increased 0.65% or $0.03 during the last trading session, reaching $4.66. About 21.16M shares traded or 145.67% up from the average. Gerdau S.A. (NYSE:GGB) has risen 83.44% since January 13, 2017 and is uptrending. It has outperformed by 66.74% the S&P500.

Marsico Capital Management Llc decreased Amgen Inc (AMGN) stake by 8.91% reported in 2017Q3 SEC filing. Marsico Capital Management Llc sold 11,899 shares as Amgen Inc (AMGN)’s stock declined 9.68%. The Marsico Capital Management Llc holds 121,696 shares with $22.69M value, down from 133,595 last quarter. Amgen Inc now has $134.32 billion valuation. The stock increased 1.69% or $3.08 during the last trading session, reaching $185.04. About 3.11M shares traded or 13.87% up from the average. Amgen Inc. (NASDAQ:AMGN) has risen 5.27% since January 13, 2017 and is uptrending. It has underperformed by 11.43% the S&P500.

Investors sentiment decreased to 0.99 in 2017 Q3. Its down 0.16, from 1.15 in 2017Q2. It fall, as 58 investors sold AMGN shares while 511 reduced holdings. 108 funds opened positions while 453 raised stakes. 555.05 million shares or 0.41% less from 557.32 million shares in 2017Q2 were reported. Afam Inc reported 57,579 shares or 1.3% of all its holdings. Connor Clark And Lunn Invest Mgmt Limited holds 0.17% or 150,750 shares in its portfolio. Page Arthur B stated it has 4,875 shares. Cap Mgmt Va holds 2.79% in Amgen Inc. (NASDAQ:AMGN) or 52,322 shares. Schwartz Inv Counsel Inc reported 3.08% stake. Dodge Cox holds 27,837 shares or 0% of its portfolio. Clarivest Asset Management Ltd Liability reported 1.39% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Oarsman Cap Inc reported 0.54% in Amgen Inc. (NASDAQ:AMGN). Ssi Management has invested 0.04% in Amgen Inc. (NASDAQ:AMGN). Legacy Capital Prtn has invested 0.43% in Amgen Inc. (NASDAQ:AMGN). Fmr Limited Liability Corporation stated it has 59.04M shares or 1.33% of all its holdings. Kames Capital Plc holds 0.07% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 14,577 shares. Aimz Inv Advisors Llc has invested 2.62% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Moreover, Eagle Capital Management Ltd Llc has 1.81% invested in Amgen Inc. (NASDAQ:AMGN) for 17,016 shares. Capital Glob Invsts reported 2.95% stake.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on February, 1. They expect $3.02 EPS, up 4.50% or $0.13 from last year’s $2.89 per share. AMGN’s profit will be $2.19B for 15.32 P/E if the $3.02 EPS becomes a reality. After $3.27 actual EPS reported by Amgen Inc. for the previous quarter, Wall Street now forecasts -7.65% negative EPS growth.

Marsico Capital Management Llc increased Netflix Inc (NASDAQ:NFLX) stake by 119,885 shares to 328,420 valued at $59.56M in 2017Q3. It also upped Vantiv Inc (NYSE:VNTV) stake by 58,479 shares and now owns 114,316 shares. Sherwin Williams Co (NYSE:SHW) was raised too.

Since October 9, 2017, it had 0 insider purchases, and 2 selling transactions for $553,240 activity. Harper Sean E also sold $283,574 worth of Amgen Inc. (NASDAQ:AMGN) shares.

Among 24 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 13 Hold. Therefore 46% are positive. Amgen Inc. had 74 analyst reports since August 3, 2015 according to SRatingsIntel. UBS maintained the stock with “Neutral” rating in Wednesday, July 26 report. Oppenheimer maintained it with “Buy” rating and $18900 target in Monday, June 26 report. BMO Capital Markets maintained Amgen Inc. (NASDAQ:AMGN) on Friday, October 20 with “Hold” rating. Argus Research maintained the shares of AMGN in report on Monday, February 8 with “Buy” rating. BMO Capital Markets maintained Amgen Inc. (NASDAQ:AMGN) on Friday, July 21 with “Buy” rating. The stock of Amgen Inc. (NASDAQ:AMGN) has “Hold” rating given on Friday, September 22 by BMO Capital Markets. The company was maintained on Wednesday, September 28 by Citigroup. The firm has “Buy” rating given on Wednesday, August 23 by Oppenheimer. On Friday, September 29 the stock rating was maintained by Credit Suisse with “Outperform”. Raymond James initiated Amgen Inc. (NASDAQ:AMGN) on Tuesday, September 1 with “Market Perform” rating.

Among 7 analysts covering Gerdau (NYSE:GGB), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Gerdau had 10 analyst reports since August 10, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, October 25 by Scotia Capital. The stock of Gerdau S.A. (NYSE:GGB) earned “Overweight” rating by Morgan Stanley on Thursday, August 18. Goldman Sachs initiated Gerdau S.A. (NYSE:GGB) on Monday, August 10 with “Buy” rating. JP Morgan upgraded the stock to “Overweight” rating in Friday, September 1 report. The firm has “Underperform” rating given on Monday, February 22 by Bank of America. The firm earned “Hold” rating on Thursday, September 7 by Credit Suisse. Bank of America upgraded the shares of GGB in report on Monday, November 27 to “Buy” rating. The stock has “Outperform” rating by Credit Suisse on Thursday, August 4. J.P. Morgan upgraded the stock to “Buy” rating in Friday, September 1 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :